Roles of oral bacteria in cardiovascular diseases - From molecular mechanisms to clinical cases: Treatment of periodontal disease regarded as biofilm infection: Systemic administration of azithromycin

Journal of Pharmacological Sciences

Volumn 113, Issue 2, 2010, Pages 126-133

  Wang, Pao Li ^a  

^a OSAKA DENTAL UNIVERSITY   (Japan)

Author keywords

Aggressive periodontitis; Azithromycin; Biofilm; Oral bacteria; Systemic administration

Indexed keywords

ADHESIN; AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; JOSAMYCIN; MINOCYCLINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; CASE REPORT; DRUG STRUCTURE; FEMALE; HUMAN; IN VITRO STUDY; PERIODONTAL DISEASE; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STREPTOCOCCUS GORDONII; BACTERIAL INFECTION; CHRONIC PERIODONTITIS; MICROBIOLOGY;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL INFECTIONS; BIOFILMS; CHRONIC PERIODONTITIS; FEMALE; HUMANS;

EID: 77953823872     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09R25FM     Document Type: Article

References (15)

1. 14th International Conference on Oral Biology, 1996. Biofilm on oral surface: Implications for Health and Disease. Adv Dental Res.
2. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol. 1995;49:711-745.
3. Kolenbrander PE, London J. Adhere today, here tomorrow: oral bacterial adherence. J Bacteriol. 1993;175:3247-3252.
4. Marsh P, Martin M. Oral microbiology. 3rd ed. London: Chapman and Hall;1992.
5. Wang PL, Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors. Crit Rev Oral Biol Med. 2002;13:132-142.
6. Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol 2000. 2002;28:12-55.
7. Tateda K, Comte R, Pechere JC, Kohler T, Yamaguchi K, Van Delden C. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2001;45:1930-1933.
8. Nagino K, Kobayashi H. Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudomonas aeruginosa. Clin Microbiol Infect. 1997;3:432-439.
9. Tamura A, Ara T, Imamura Y, Fujii T, Wang PL. The effects of antibiotics on in vitro biofilm model of periodontal disease. Eur J Med Res. 2008;13:439-445.
10. Fujii T, Wang PL, Hosokawa S, Tamura A, Hikita K, Maida T, et al. Effect of systemically administrated azithromycin in early onset aggressive periodontitis. Perio. 2004;1:321-325.
11. Smith SR, Foyle DM, Daniels J, Joyston-Bechal S, Smales FC, Sefton A, et al. A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results. J Clin Periodontol. 2002;29:54-61.
12. Mascarenhas P, Gapski R, Al-Shammari K, Hill R, Soehren S, Fenno JC, et al. Clinical response of azithromycin as an adjunct to non-surgical periodontal therapy in smokers. J Periodontol. 2005;76:426-436.
13. Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol. 2007;34:243-253.
14. Gomi K, Yashima A, Nagano T, Kanazashi M, Maeda N, Arai T. Effects of full-mouth scaling and root planing in conjunction with systemically administered azithromycin. J Periodontol. 2007;78:422-429.
15. Haas AN, de Castro GD, Moreno T, Susin C, Albandar JM, Oppermann RV, et al. Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial. J Clin Periodontol. 2008;35:696-704.